Specific inhibition of carbonic anhydrase IX activity enhances the in vivo therapeutic effect of tumor irradiation
- 30 June 2011
- journal article
- research article
- Published by Elsevier BV in Radiotherapy and Oncology
- Vol. 99 (3), 424-431
- https://doi.org/10.1016/j.radonc.2011.05.045
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Targeting Tumor Hypoxia: Suppression of Breast Tumor Growth and Metastasis by Novel Carbonic Anhydrase IX InhibitorsCancer Research, 2011
- Selective Inhibition of Carbonic Anhydrase IX Decreases Cell Proliferation and Induces Ceramide-Mediated Apoptosis in Human Cancer CellsJournal of Pharmacology and Experimental Therapeutics, 2010
- Imaging of CA IX with fluorescent labelled sulfonamides distinguishes hypoxic and (re)-oxygenated cells in a xenograft tumour modelRadiotherapy and Oncology, 2009
- Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IXProceedings of the National Academy of Sciences of the United States of America, 2009
- In vivo targeting of tumor-associated carbonic anhydrases using acetazolamide derivativesBioorganic & Medicinal Chemistry Letters, 2009
- Carbonic anhydrases: novel therapeutic applications for inhibitors and activatorsNature Reviews Drug Discovery, 2008
- Imaging the hypoxia surrogate marker CA IX requires expression and catalytic activity for binding fluorescent sulfonamide inhibitorsRadiotherapy and Oncology, 2007
- Hypoxia activates the capacity of tumor‐associated carbonic anhydrase IX to acidify extracellular pHFEBS Letters, 2004
- Diagnostic, prognostic and therapeutic implications of carbonic anhydrases in cancerBritish Journal of Cancer, 2003
- Causes and consequences of tumour acidity and implications for treatmentMolecular Medicine Today, 2000